SNPMiner Trials by Shray Alag

SNPMiner SNPMiner Trials (Home Page)

Report for Clinical Trial NCT03523065

Developed by Shray Alag, 2020.
SNP Clinical Trial Gene

The Chinese Parkinson's Disease With GBA Variants Registry

The purpose of the Chinese Parkinson's disease with GBA variants Registry (CPD-GBAR) is to develop a database of patients of Parkinson's disease with Glucocerebrosidase (GBA) gene variants in mainland China.

NCT03523065 Parkinson Disease
MeSH:Parkinson Disease

Primary Outcomes

Description: Establish the database of Parkinson's disease with GBA variants in mainland China.

Measure: Database of Parkinson's disease with GBA variants

Time: 10 years

Description: Characterize the clinical feature of PD patients with GBA variants

Measure: Clinical feature

Time: 10 years

Time Perspective: Prospective


There is one SNP


1 L444P

GBA gene variants such as L444P can influence the risk of developing PD and these variants have the greatest impact on PD susceptibility among all the PD related gene variants yet discovered. --- L444P ---

HPO Nodes